BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35218558)

  • 1. Reconstructing the epidermal proteolytic cascades in health and disease.
    Sotiropoulou G; Zingkou E; Pampalakis G
    J Pathol; 2022 Jul; 257(4):545-560. PubMed ID: 35218558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiological and pathological roles of kallikrein-related peptidases in the epidermis.
    Kishibe M
    J Dermatol Sci; 2019 Aug; 95(2):50-55. PubMed ID: 31279501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human tissue kallikreins as promiscuous modulators of homeostatic skin barrier functions.
    Eissa A; Diamandis EP
    Biol Chem; 2008 Jun; 389(6):669-80. PubMed ID: 18627299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profiling system for skin kallikrein proteolysis applied in gene-deficient mouse models.
    Horn M; Zbodakova O; Kasparek P; Srp J; Haneckova R; Hradilek M; Mares M; Sedlacek R
    Biol Chem; 2018 Sep; 399(9):1085-1089. PubMed ID: 29885275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elimination of KLK5 inhibits early skin tumorigenesis by reducing epidermal proteolysis and reinforcing epidermal microstructure.
    Pampalakis G; Zingkou E; Kaklamanis L; Spella M; Stathopoulos GT; Sotiropoulou G
    Biochim Biophys Acta Mol Basis Dis; 2019 Nov; 1865(11):165520. PubMed ID: 31381994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KLK5 Inactivation Reverses Cutaneous Hallmarks of Netherton Syndrome.
    Furio L; Pampalakis G; Michael IP; Nagy A; Sotiropoulou G; Hovnanian A
    PLoS Genet; 2015 Sep; 11(9):e1005389. PubMed ID: 26390218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kallikrein-related peptidases: bridges between immune functions and extracellular matrix degradation.
    Sotiropoulou G; Pampalakis G
    Biol Chem; 2010 Apr; 391(4):321-31. PubMed ID: 20180637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteolytic activation cascade of the Netherton syndrome-defective protein, LEKTI, in the epidermis: implications for skin homeostasis.
    Fortugno P; Bresciani A; Paolini C; Pazzagli C; El Hachem M; D'Alessio M; Zambruno G
    J Invest Dermatol; 2011 Nov; 131(11):2223-32. PubMed ID: 21697885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The emerging roles of serine protease cascades in the epidermis.
    Ovaere P; Lippens S; Vandenabeele P; Declercq W
    Trends Biochem Sci; 2009 Sep; 34(9):453-63. PubMed ID: 19726197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Keratinocyte differentiation and proteolytic pathways in skin (patho) physiology.
    Zingkou E; Pampalakis G; Sotiropoulou G
    Int J Dev Biol; 2022; 66(1-2-3):269-275. PubMed ID: 34881788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the kallikrein-related peptidases for drug development.
    Sotiropoulou G; Pampalakis G
    Trends Pharmacol Sci; 2012 Dec; 33(12):623-34. PubMed ID: 23089221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kallikreins: Essential epidermal messengers for regulation of the skin microenvironment during homeostasis, repair and disease.
    Nauroy P; Nyström A
    Matrix Biol Plus; 2020 May; 6-7():100019. PubMed ID: 33543017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kallikreins emerge as new regulators of viral infections.
    Pampalakis G; Zingkou E; Panagiotidis C; Sotiropoulou G
    Cell Mol Life Sci; 2021 Nov; 78(21-22):6735-6744. PubMed ID: 34459952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matriptase and prostasin proteolytic activities are differentially regulated in normal and wounded skin.
    Chang SC; Chiang CP; Lai CH; Du PA; Hung YS; Chen YH; Yang HY; Fang HY; Lee SP; Tang HJ; Wang JK; Johnson MD; Lin CY
    Hum Cell; 2020 Oct; 33(4):990-1005. PubMed ID: 32617892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matriptase initiates activation of epidermal pro-kallikrein and disease onset in a mouse model of Netherton syndrome.
    Sales KU; Masedunskas A; Bey AL; Rasmussen AL; Weigert R; List K; Szabo R; Overbeek PA; Bugge TH
    Nat Genet; 2010 Aug; 42(8):676-83. PubMed ID: 20657595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue kallikrein proteolytic cascade pathways in normal physiology and cancer.
    Pampalakis G; Sotiropoulou G
    Biochim Biophys Acta; 2007 Sep; 1776(1):22-31. PubMed ID: 17629406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transgenic Kallikrein 14 Mice Display Major Hair Shaft Defects Associated with Desmoglein 3 and 4 Degradation, Abnormal Epidermal Differentiation, and IL-36 Signature.
    Gouin O; Barbieux C; Leturcq F; Bonnet des Claustres M; Petrova E; Hovnanian A
    J Invest Dermatol; 2020 Jun; 140(6):1184-1194. PubMed ID: 32169475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of kallikreins in inflammatory skin disorders and their potential as therapeutic targets.
    Di Paolo CT; Diamandis EP; Prassas I
    Crit Rev Clin Lab Sci; 2021 Jan; 58(1):1-16. PubMed ID: 32568598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-linking of SPINK6 by transglutaminases protects from epidermal proteases.
    Fischer J; Koblyakova Y; Latendorf T; Wu Z; Meyer-Hoffert U
    J Invest Dermatol; 2013 May; 133(5):1170-7. PubMed ID: 23303447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of kallikrein-related peptidases in the skin - from physiology to diseases to therapeutic options.
    Fischer J; Meyer-Hoffert U
    Thromb Haemost; 2013 Sep; 110(3):442-9. PubMed ID: 23446429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.